Metabolites from python blood have the potential to lead to the creation of weight-loss medications similar to Ozempic, according to new research. At first, scientists at Stanford University, Baylor ...

OpenAI has agreed to acquire Astral, a startup behind widely used Python development tools, in a deal designed to sharpen its ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

March 19 (Reuters) - OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT ​owner looks to ...

Scientists have discovered a novel metabolite in pythons that quells appetite without causing gastrointestinal side effects ...